113 related articles for article (PubMed ID: 9333486)
1. [The comparative characteristics of the clinico-hematological indices in patients with different forms of myelodysplasias].
Pesotskaia LA
Lik Sprava; 1997; (2):59-62. PubMed ID: 9333486
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis, course and outcome of myelodysplasias].
Riauzova LIu; Soloveĭ DIa; Iavorkovskiĭ LI; Iavorkovskiĭ LL; Grinberg LIa
Gematol Transfuziol; 1988 Aug; 33(8):19-23. PubMed ID: 3192050
[No Abstract] [Full Text] [Related]
3. [Clinical, hematologic and developmental characteristics of myelodysplastic syndromes. Study of a group of patients with a long-term follow-up].
Di Giovanni S; Giallonardo P; Costa MP; Carducci P
Recenti Prog Med; 1987 Feb; 78(2):63-8. PubMed ID: 3473582
[No Abstract] [Full Text] [Related]
4. [Myelodysplastic syndromes].
Sainty D; Horschowski N; Fossat C; Sampol J
Ann Biol Clin (Paris); 1985; 43(6):821-30. PubMed ID: 3914223
[No Abstract] [Full Text] [Related]
5. Leukocyte alkaline phosphatase score correlation with bone marrow blast percentage in myelodysplastic syndrome.
Lipshitz J; Limaye S; Patel D
Acta Haematol; 2010; 124(3):179-81. PubMed ID: 20962518
[No Abstract] [Full Text] [Related]
6. [The morphofunctional characteristics of the bone marrow erythroid cells in some forms of the myelodysplastic syndrome].
Sarycheva TG; Tsvetaeva NV; Kozinets GI
Ter Arkh; 1993; 65(7):52-4. PubMed ID: 8211781
[TBL] [Abstract][Full Text] [Related]
7. Myelodysplastic syndromes in childhood: description of seven cases.
Vitale A; Testi AM; Moleti ML; Vignetti M; Arcese W; Fenu S; Cedrone M; De Felice L; Amadori S; Mandelli F
Ann Hematol; 1994 May; 68(5):241-5. PubMed ID: 8018765
[TBL] [Abstract][Full Text] [Related]
8. [Myelodysplastic syndromes: current diagnosis and classification].
Tsvetaeva NV; Zavadenko MA; Ol'shanskaia IuV; Glasko EN; Khoroshko ND
Ter Arkh; 2001; 73(4):62-6. PubMed ID: 11494452
[No Abstract] [Full Text] [Related]
9. Classification of the myelodysplastic syndromes.
Bennett JM
Clin Haematol; 1986 Nov; 15(4):909-23. PubMed ID: 3471370
[No Abstract] [Full Text] [Related]
10. [Diagnosis in the myelodysplastic syndrome].
Hunstein W; Ho AD
Dtsch Med Wochenschr; 1987 Jan; 112(2):60-2. PubMed ID: 3542464
[No Abstract] [Full Text] [Related]
11. [Myelodysplastic syndrome. Main symptoms: mostly nonspecific anemia symptoms].
Kolyvanos Naumann U; Nigg C; Käser L; Vetter W
Praxis (Bern 1994); 2005 Jul; 94(28-29):1095-100; quiz 1101. PubMed ID: 16078749
[No Abstract] [Full Text] [Related]
12. [Myelodysplastic syndrome].
Urabe A
Gan To Kagaku Ryoho; 2005 Mar; 32(3):287-91. PubMed ID: 15791810
[TBL] [Abstract][Full Text] [Related]
13. [Myelodysplasias: clinical experience with 35 patients].
Chuecas F; Grebe G; Jalil R; Lira P
Rev Med Chil; 1990 Nov; 118(11):1211-7. PubMed ID: 2152645
[TBL] [Abstract][Full Text] [Related]
14. [Myelodysplastic diseases in childhood].
Niemeyer C; Stollmann-Gibbels B; Ebell W; Gaedicke G; Creutzig U
Klin Padiatr; 1992; 204(4):190-7. PubMed ID: 1518255
[TBL] [Abstract][Full Text] [Related]
15. [The clinicopathological evaluation of automated cytochemical hematology system (Technicon H1) in patients with leukemia and myelodysplastic syndrome].
Koui F; Chiba T
Rinsho Byori; 1992 Jun; 40(6):586-94. PubMed ID: 1513030
[TBL] [Abstract][Full Text] [Related]
16. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of dysmyelopoiesis in cats: 34 cases (1996-2005).
Weiss DJ
J Am Vet Med Assoc; 2006 Mar; 228(6):893-7. PubMed ID: 16536701
[TBL] [Abstract][Full Text] [Related]
18. Retinal mass in a case of pediatric myelodysplastic syndrome (refractory anemia with excess of blasts).
Basu B
Eur J Ophthalmol; 2010; 20(3):618-20. PubMed ID: 20037898
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of the Fas ligand on peripheral blood mononuclear cells and undetectable levels of soluble Fas ligand in the serum of patients with aplastic anemia and myelodysplastic syndrome.
Shinohara K; Takahahi T; Nawata R; Oeda E
Am J Hematol; 1999 Oct; 62(2):124-5. PubMed ID: 10509009
[No Abstract] [Full Text] [Related]
20. Myelodysplastic syndrome evolving into a myeloproliferative disorder: one disease or two?
Ohyashiki K; Yokoyama K; Kimura Y; Ohyashiki JH; Ito T; Kuratsuji T; Komatsumoto S; Nara M; Toyama K
Leukemia; 1993 Feb; 7(2):338-40. PubMed ID: 8426488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
